Affymetrix and PathGEN Dx Partner to Develop Pathogen Detection Kit
Affymetrix, Inc.and PathGEN Dx Pte. Ltd., a spin-off molecular diagnostics company founded by researchers from the Genome Institute of Singapore, have signed a Powered by Affymetrix (PbA) Program agreement.
Under this PbA agreement, PathGEN Dx will develop an in-vitro diagnostic kit for comprehensive pathogen detection using their PathGEN®PathChip and is based on a patented, efficient, and accurate microarray-based protocol and analysis method. The kit will be comprised of PathGEN Dx's proprietary reagents, an automated software package, and a contract manufactured GeneChip® microarray from Affymetrix. It will detect the presence of more than 70,000 viral and bacterial genomes from a wide variety of human samples, annotate the genomic information, and identify co-infecting pathogens.
Dr. Martin Hibberd, PathGEN Dx Co-Founder, said, This will be the start of our development plan for a diagnostic microarray that we feel will ultimately help medical researchers and surveillance investigators identify the full range of viruses and bacteria in their samples.
Tags: Automation, Pathogen
Date Published: August 27, 2012
Testing for Foodborne Pathogens in your Operation? Consider Puritan
New Software Improves Antibiotic SIR Determination Using Latest EUCAST Rules
Screw Cap Specially Optimized for Automated Handling
Integra Competition Offers ASSIST PLUS Pipetting Robot Prize
COPAN Defining the Future of Human Robot Collaboration in Clinical Microbiology